Application of levosimendan (Simdax®) for heart failure of III-IV functional class after nypha. Direct hemodynamical follow-up of 14 patients within 48 hours.
Year: 2007
Type: article
Authors: M Grigorov, Boris Zehirov, Г Григоров, Georgi Todorov, Галина Георгиева, M. Heykova
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W31030497
